[LRMR] YoY Quarter Result on 31-Mar-2020 [#Q1]

Stock
[LRMR] Larimar Therapeutics, Inc.
Announcement Date
07-May-2020
Financial Year
2020
Quarter
31-Mar-2020 [#Q1]
Profit Trend
QoQ- -9.84%
YoY- -133,380.00%
Quarter Report
LRMR's Result
LRMR's Financial Summary
View:
Show?
Quarter Result
31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -6,526 -8,943 -12,088 -6,674 -5 -15,956 -13,011 -10.85%
Tax -1,111 56 0 -35 330 0 0 -
NP -5,415 -8,999 -12,088 -6,674 -5 -15,956 -13,011 -13.58%
Tax Rate - - - - - - - -
Total Cost 5,415 8,999 12,088 6,674 5 15,956 13,011 -13.58%
Ratio Analysis
31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 CAGR
EPS -0.12 -0.49 -0.76 -0.72 -0.00 -5.79 -4.76 -45.83%
EPS Diluted -0.12 -0.49 -0.76 -0.72 -0.00 -5.79 -4.76 -45.83%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.